New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 23, 2014
07:37 EDTPRGOPerrigo near-term outlook has improved, says RBC Capital
RBC Capital expects Perrigo to benefit from several positive catalysts, including lower buyside expectations, tailwinds for the company's consumer health business, and increased focus on its Tysabri SPMS opportunity. The firm keeps a $160 price target and Outperform rating on the shares.
News For PRGO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 29, 2014
07:41 EDTPRGOPerrigo announces out-licensing of preclinical assets to Imago Pharmaceuticals
Subscribe for More Information
07:17 EDTPRGOLumara Health to be acquired in two separate transactions for $1.11B
Subscribe for More Information
07:11 EDTPRGOPerrigo acquires women's health product portfolio from Lumara for $82M
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use